OraSure Technologies | OSUR - 资产



金融业
股票价格
USD
资产
USD 360.55M
现金及等价物
USD 160.58M
销售成本
USD 15.43M
流动资产
USD 222.94M
流动负债
USD 25.12M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 317.78M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 263.5M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.07M
贸易债权人
USD 8.4M
应收帐款人
USD 22.2M


资产 更改 日
Agilent USD 13.97B 902M 2026-06
AngioDynamics USD 269.68M 4.04M 2025-09
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Bio Techne USD 2.59B 36.12M 2026-06
Bio-Rad Laboratories USD 10.25B 462M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Cerus USD 221.86M 6.67M 2025-12
Charles River Laboratories USD 7.53B 198.16M 2026-06
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.2B 25M 2026-06
Dexcom USD 6.46B 178M 2026-06
Illumina USD 6.65B 91M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Mesa Laboratories USD 434.85M 4.5M 2025-12
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Quidel USD 5.72B 86.6M 2026-06
Repligen USD 2.95B 19.41M 2026-06
Revvity USD 12.05B 49.24M 2026-06
STAAR Surgical USD 475.2M 24.09M 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Trinity Biotech USD 105.16M 1.45M 2025-12
Waters USD 24.75B 220M 2026-06